Optimal Bayesian-feasible dose escalation for cancer phase I trials (Q1265963): Difference between revisions
From MaRDI portal
Changed an Item |
Set profile property. |
||
| Property / MaRDI profile type | |||
| Property / MaRDI profile type: MaRDI publication profile / rank | |||
Normal rank | |||
Revision as of 02:44, 5 March 2024
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Optimal Bayesian-feasible dose escalation for cancer phase I trials |
scientific article |
Statements
Optimal Bayesian-feasible dose escalation for cancer phase I trials (English)
0 references
6 January 1999
0 references
Bayesian adaptive procedure
0 references
constrained optimization
0 references
Bayesian feasible scheme
0 references
dose escalation scheme
0 references
cancer phase I clinical trials
0 references
